Tata Sons’ board approved a significant Rs 10,000 crore capital infusion for Air India. This investment is contingent upon business case presentations from the airline and other ventures. The decision follows a pause in equity injections after Air India’s doubled losses in FY26. Tata Sons’ ability to provide guarantees is also constrained by an RBI application. Singapore Airlines may need to invest Rs 3,350 crore to maintain its stake.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.